NDC 63629-1830-07 - SPIRONOLACTONE

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
63629-1830
Requested NDC
63629-1830-07
Package NDCs from labels
63629-1830-1, 63629-1830-2, 63629-1830-3, 63629-1830-4, 63629-1830-5, 63629-1830-6, 63629-1830-8, 63629-1830-9, 63629-1830-7, 63629-1830-07
Manufacturer
Bryant Ranch Prepack
Effective date
2026-09-09
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
SPIRONOLACTONE - Bryant Ranch PrepackBryant Ranch Prepack2026-09-09HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
63629-1830-12020-10-16These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-12020-10-16These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-22020-10-16These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-22020-10-16These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-32020-10-16These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-32020-10-16These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-42020-10-16These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-42020-10-16These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-52020-10-16These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-52020-10-16These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-62020-10-16These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-62020-10-16These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-12020-01-31These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-12020-01-31These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-22020-01-31These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-22020-01-31These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-32020-01-31These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-32020-01-31These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-42020-01-31These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-42020-01-31These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-52020-01-31These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-52020-01-31These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-62020-01-31These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-62020-01-31These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63629-1830-1SPIRONOLACTONE30 in 1 BOTTLETABLET3014
63629-1830-2SPIRONOLACTONE60 in 1 BOTTLETABLET6014
63629-1830-3SPIRONOLACTONE90 in 1 BOTTLETABLET9014
63629-1830-4SPIRONOLACTONE14 in 1 BOTTLETABLET1414
63629-1830-5SPIRONOLACTONE100 in 1 BOTTLETABLET10014
63629-1830-6SPIRONOLACTONE7 in 1 BOTTLETABLET714
63629-1830-7SPIRONOLACTONE10 in 1 BOTTLETABLET1014
63629-1830-8SPIRONOLACTONE180 in 1 BOTTLETABLET18014
63629-1830-9SPIRONOLACTONE45 in 1 BOTTLETABLET4514

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63629-1830SPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]13Current NDC, Legacy NDC, 9 package rows20230406_2efb4720-625f-6616-b6f0-8b13a17c9d7e.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
63629-1830-1EA - Each63629-1830233b145f-3857-4aa7-bc6c-0ae88ededa6812012-07-24
63629-1830-2EA - Each63629-1830a464c793-83dd-4769-9646-4b19d51ccbd112012-07-24
63629-1830-3EA - Each63629-183084d6edb6-0bba-4ad8-b17a-e5206808bcc512012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
SPIRONOLACTONEACTIVE INGREDIENT27O7W4T232SPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]3
SPIRONOLACTONEACTIVE MOIETY27O7W4T232SPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]3
ANHYDROUS LACTOSEINACTIVE INGREDIENT3SY5LH9PMKSPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]3
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61USPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]3
CROSPOVIDONEINACTIVE INGREDIENT68401960MKSPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]3
DOCUSATE SODIUMINACTIVE INGREDIENTF05Q2T2JA0SPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]3
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30SPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]3
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4SPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]3
SODIUM BENZOATEINACTIVE INGREDIENTOJ245FE5EUSPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]3
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2SPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]3

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 56 · 1,115 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CVS Mini EnemaDOCUSATE SODIUM W/BENZOCAINECVS HEALTHca00c520-410a-1905-e053-2995a90a56f02026-10-23WarningsExact identifier
unii: F05Q2T2JA0
Stool Softener LaxativeDOCUSATE SODIUMATLANTIC BIOLOGICALS CORP.c1f588d0-4600-4b97-b2d3-2c08ac351e072026-10-23WarningsExact identifier
unii: F05Q2T2JA0
Clear Eyes Triple ReliefPOLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDEPrestige Brands Holdings, Inc.1269a1a6-843d-4d08-bb3c-c1f3d2e7080d2026-10-23WarningsExact identifier
unii: FZ989GH94E
spironolactoneSPIRONOLACTONEMajor Pharmaceuticals0c45d793-6f2f-4622-b5ed-6875acfbc02b2026-10-20Warnings, Adverse reactionsExact identifier
rxcui: 313096
unii: 27O7W4T232
Docusate SodiumDOCUSATE SODIUMPD-Rx Pharmaceuticals, Inc.6a7e4193-22d2-491e-9842-5c43f571fc652026-10-16WarningsExact identifier
unii: F05Q2T2JA0
SpironolactoneSPIRONOLACTONEA-S Medication Solutions08738ad4-1607-4d55-af71-6790477353bd2026-10-08Warnings, Adverse reactionsExact identifier
rxcui: 198222
unii: 27O7W4T232
SpironolactoneSPIRONOLACTONEA-S Medication Solutionsbb29ea6f-c294-4895-9e9b-544d69651a352026-10-08Warnings, Adverse reactionsExact identifier
rxcui: 313096
unii: 27O7W4T232
SpironolactoneSPIRONOLACTONEA-S Medication Solutionsc328f555-2da8-43ac-bc04-0e89d4d2aa532026-10-07Warnings, Adverse reactionsExact identifier
rxcui: 198223
unii: 27O7W4T232
SpironolactoneSPIRONOLACTONEAphena Pharma Solutions - Tennessee, LLC5d407f3f-fc59-331d-e063-6394a90ac10c2026-10-07Warnings, Adverse reactionsExact identifier
rxcui: 313096
unii: 27O7W4T232
MiraSOFT Stool SoftenerDOCUSATE SODIUMBayer HealthCare LLC.5851f15f-8add-559f-e063-6394a90a7b7d2026-10-07WarningsExact identifier
unii: F05Q2T2JA0
SPIRONOLACTONESPIRONOLACTONEAurobindo Pharma Limited768563dc-a619-44dc-b97f-1a7e71fd56a02026-10-07Warnings, Adverse reactionsExact identifier
rxcui: 198222
rxcui: 313096
rxcui: 198223
unii: 27O7W4T232
SPIRONOLACTONESPIRONOLACTONEBryant Ranch Prepack50f89f67-5991-4645-8656-01f4dd507c5f2026-10-02Warnings, Adverse reactionsExact identifier
rxcui: 198222
unii: 27O7W4T232
SPIRONOLACTONESPIRONOLACTONEBryant Ranch Prepacka32c43d3-a13b-4e6c-b2dd-5dc46fef5b002026-10-02Warnings, Adverse reactionsExact identifier
rxcui: 198223
unii: 27O7W4T232
SPIRONOLACTONESPIRONOLACTONEBryant Ranch Prepack711f5042-9d88-4546-a347-532dfb94313e2026-10-02Warnings, Adverse reactionsExact identifier
rxcui: 313096
unii: 27O7W4T232
SENNA-PLUSSENNOSIDES AND DOCUSATE SODIUMPreferred Pharmaceuticals Inc.d7146449-c43e-460a-9ae0-aa1966eaa3b62026-10-01WarningsExact identifier
unii: F05Q2T2JA0
Stool Softener LaxativeDOCUSATE SODIUMEQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)6484c373-697f-4a81-a375-8cb97223a42c2026-09-23WarningsExact identifier
unii: F05Q2T2JA0
Lymph Tonic IIECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANABioActive Nutritional, Inc.0e3265b0-b210-4a4c-80d2-8a9712981d4e2026-09-17WarningsExact identifier
unii: ETJ7Z6XBU4
REFRESH ClassicPOLYVINYL ALCOHOL, POVIDONEAllergan, Inc.31bf1d6c-9719-4060-b6a3-409a2fe7b5602026-09-15WarningsExact identifier
unii: FZ989GH94E
spironolactoneSPIRONOLACTONEREMEDYREPACK INC.8b76a904-6c99-485a-a05f-13a36c5f720c2026-09-15Warnings, Adverse reactionsExact identifier
rxcui: 198222
unii: 27O7W4T232
Right Remedies Stool Softener Clear - Docusate Sodium 50mg softgelRIGHT REMEDIES STOOL SOFTENER CLEAR SOFTGELStrive Pharmaceuticals Inc.5b887888-fef3-13cd-e063-6294a90a841e2026-09-15WarningsExact identifier
unii: F05Q2T2JA0

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.